Advertisement

Topics

NICE backs Gilead’s hepatitis C drug Epclusa

09:28 EDT 23 Sep 2016 | thePharmaLetter

The National Institute for Health and Care Excellence (NICE) thas recommended Epclusa (sofosbuvir-velpatasvir),…

Original Article: NICE backs Gilead’s hepatitis C drug Epclusa

NEXT ARTICLE

More From BioPortfolio on "NICE backs Gilead’s hepatitis C drug Epclusa"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...